Additionally, the inhibition of CD47, a ligand for the macrophage-associated signal-regulatory protein α (SIRPα) has been shown to increase phagocytosis of EC tumor cells by TAMs (139), although CD47- SIRPα pathway inhibition has not yet been considered for clinical trial. The gene discussed is SIRPA; the disease is neoplasm.